|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2002-5-28
|
|
pubmed:abstractText |
The objective of the study was to evaluate the safety and efficacy of high-concentration intranasal desmopressin (HCIN-DDAVP) 1.5 mg/mL, in patients weighing < or = 50 kg with mild hemophilia A or mild type 1 von Willebrand disease (VWD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0022-3476
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
140
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
595-9
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:12032528-Administration, Intranasal,
pubmed-meshheading:12032528-Adolescent,
pubmed-meshheading:12032528-Analysis of Variance,
pubmed-meshheading:12032528-Child,
pubmed-meshheading:12032528-Child, Preschool,
pubmed-meshheading:12032528-Deamino Arginine Vasopressin,
pubmed-meshheading:12032528-Female,
pubmed-meshheading:12032528-Hemophilia A,
pubmed-meshheading:12032528-Hemostatics,
pubmed-meshheading:12032528-Humans,
pubmed-meshheading:12032528-Infant,
pubmed-meshheading:12032528-Infusions, Intravenous,
pubmed-meshheading:12032528-Male,
pubmed-meshheading:12032528-von Willebrand Diseases
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Evaluation of high concentration intranasal and intravenous desmopressin in pediatric patients with mild hemophilia A or mild-to-moderate type 1 von Willebrand disease.
|
|
pubmed:affiliation |
Blood Center of Southeastern Wisconsin, Medical College of Wisconsin, Milwaukee, 53201-2178, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
